Target intelligence / Profile preview

DNA polymerase alpha 2 accessory subunit (POLA2)

Target
POLA2
Molecular classification
Enzyme, Accessory subunit, DNA-directed DNA polymerase complex component, Other
01

Overview

DNA polymerase alpha 2 accessory subunit (POLA2) is a non-catalytic, accessory protein component of the DNA polymerase alpha complex, a key multisubunit enzyme essential for the initiation of eukaryotic DNA replication. POLA2 forms a stable heterodimer with the catalytic subunit (POLA1) and serves as a structural and regulatory scaffold, mediating recruitment of the polymerase–primase complex to replication forks, and facilitating primer synthesis and early DNA strand extension[1][2][4]. POLA2 is crucial for both the initiation of DNA synthesis and for telomere C-strand maintenance. Pathogenic variants in POLA2 can cause developmental disorders with short telomeres, and its malfunction may contribute to broader replication stress-associated diseases[2][4]. While there are no drugs directly targeting POLA2, its central role in DNA replication makes it of fundamental interest for understanding genome duplication and maintenance.

Other names
DNA polymerase alpha subunit BFLJ21662DNA polymerase alpha 70 kDa subunitpolymerase (DNA-directed) alpha 2 (70kD subunit)polymerase (DNA) alpha 2 accessory subunitDPOA2
02

Biological functions

DNA replication initiationDNA synthesisPrimer synthesis (via primase activity in complex)Telomere C-strand fill-inDouble-strand break repair
03

Disease associations

Developmental disorders (e.g., Van Esch–O’Driscoll syndrome)Disorders linked to telomere dysfunctionPotential role in cancer (as DNA replication defects can contribute to tumorigenesis)Other
04

Safety considerations

Potential impairment of DNA replication with inhibition or loss of functionRisk of genomic instabilityEffects on rapidly proliferating cells (if targeted therapeutically)

Beyond the preview

Go deeper on DNA polymerase alpha 2 accessory subunit (POLA2).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on DNA polymerase alpha 2 accessory subunit (POLA2).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call